A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Genentech, Inc.
Genentech, Inc.
Hoffmann-La Roche
Fudan University
Hoffmann-La Roche
Sun Yat-sen University
Fondazione per la Medicina Personalizzata